Free tool
FAERS Monitor: Venlafaxine Besylate
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 215429 or its brand name (Venlafaxine Besylate, Venlafaxine Besylate). Reports on generic versions are filed under their own applications.
Reports
58,351
Serious
48,491
83% of reports
Hospitalization
21,481
Death reported
8,442
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective3,903
- toxicity to various agents3,736
- fatigue3,326
- nausea3,255
- off label use2,815
- completed suicide2,791
- drug interaction2,670
- headache2,617
- dizziness2,416
- diarrhoea2,171
- depression2,082
- anxiety2,044
- fall1,988
- vomiting1,986
- intentional overdose1,874
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 77 |
| 2005 | 76 |
| 2006 | 13 |
| 2007 | 3 |
| 2008 | 31 |
| 2009 | 236 |
| 2010 | 656 |
| 2011 | 985 |
| 2012 | 1,428 |
| 2013 | 1,551 |
| 2014 | 1,842 |
| 2015 | 2,808 |
| 2016 | 3,305 |
| 2017 | 3,771 |
| 2018 | 4,883 |
| 2019 | 5,378 |
| 2020 | 5,208 |
| 2021 | 4,467 |
| 2022 | 4,129 |
| 2023 | 4,709 |
| 2024 | 4,784 |
| 2025 | 4,549 |
| 2026 | 3,461 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,995,808 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| completed suicideSignal | 2,791 | 12.5 | 12.0 | 28,524 |
| intentional overdoseSignal | 1,874 | 10.8 | 10.3 | 16,252 |
| toxicity to various agentsSignal | 3,736 | 8.1 | 7.9 | 23,071 |
| drug interactionSignal | 2,670 | 6.2 | 5.9 | 11,410 |
| depressionSignal | 2,082 | 3.3 | 3.2 | 3,378 |
| anxietySignal | 2,044 | 2.6 | 2.5 | 2,025 |
| fallSignal | 1,988 | 2.2 | 2.1 | 1,250 |
| dizziness | 2,416 | 1.7 | 1.7 | 790 |
| fatigue | 3,326 | 1.5 | 1.5 | 655 |
| vomiting | 1,986 | 1.5 | 1.5 | 365 |
| headache | 2,617 | 1.5 | 1.5 | 457 |
| nausea | 3,255 | 1.5 | 1.4 | 532 |
| diarrhoea | 2,171 | 1.2 | 1.2 | 83 |
| off label use | 2,815 | 1.2 | 1.1 | 64 |
| drug ineffective | 3,903 | 1.1 | 1.0 | 18 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.